184 related articles for article (PubMed ID: 11918684)
1. Regulation of inflammatory responses by natural anticoagulants.
Okajima K
Immunol Rev; 2001 Dec; 184():258-74. PubMed ID: 11918684
[TBL] [Abstract][Full Text] [Related]
2. Regulation of inflammatory responses by activated protein C: the molecular mechanism(s) and therapeutic implications.
Okajima K
Clin Chem Lab Med; 2004 Feb; 42(2):132-41. PubMed ID: 15061350
[TBL] [Abstract][Full Text] [Related]
3. Prevention of endothelial cell injury by activated protein C: the molecular mechanism(s) and therapeutic implications.
Okajima K
Curr Vasc Pharmacol; 2004 Apr; 2(2):125-33. PubMed ID: 15320513
[TBL] [Abstract][Full Text] [Related]
4. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation.
Esmon CT
Crit Care Med; 2001 Jul; 29(7 Suppl):S48-51; discussion 51-2. PubMed ID: 11445734
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis.
Esmon CT
Baillieres Best Pract Res Clin Haematol; 1999 Sep; 12(3):343-59. PubMed ID: 10856974
[TBL] [Abstract][Full Text] [Related]
6. Role of coagulation inhibitors in inflammation.
Esmon CT
Thromb Haemost; 2001 Jul; 86(1):51-6. PubMed ID: 11487041
[TBL] [Abstract][Full Text] [Related]
7. [SIRS and the coagulation of normality].
Okajima K
Rinsho Byori; 2000 Jun; 48(6):510-5. PubMed ID: 10897668
[TBL] [Abstract][Full Text] [Related]
8. [Endothelial cells and coagulation abnormalities].
Uchiba M; Okajima K
Rinsho Byori; 2000 Apr; 48(4):308-13. PubMed ID: 10810875
[TBL] [Abstract][Full Text] [Related]
9. Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation.
Choi G; Vlaar AP; Schouten M; Van't Veer C; van der Poll T; Levi M; Schultz MJ
Eur Respir J; 2007 Sep; 30(3):423-8. PubMed ID: 17537762
[TBL] [Abstract][Full Text] [Related]
10. Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats.
Harada N; Okajima K; Uchiba M
Crit Care Med; 2006 Jul; 34(7):1883-91. PubMed ID: 16641616
[TBL] [Abstract][Full Text] [Related]
11. Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production.
Murakami K; Okajima K; Uchiba M; Johno M; Nakagaki T; Okabe H; Takatsuki K
Am J Physiol; 1997 Feb; 272(2 Pt 1):L197-202. PubMed ID: 9124369
[TBL] [Abstract][Full Text] [Related]
12. Antithrombin: anti-inflammatory properties and clinical applications.
Levy JH; Sniecinski RM; Welsby IJ; Levi M
Thromb Haemost; 2016 Apr; 115(4):712-28. PubMed ID: 26676884
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience.
de Jonge E; van der Poll T; Kesecioglu J; Levi M
Semin Thromb Hemost; 2001 Dec; 27(6):667-74. PubMed ID: 11740690
[TBL] [Abstract][Full Text] [Related]
14. Effect of activated human protein C on disseminated intravascular coagulation induced by lipopolysaccharide in rats.
Aoki Y; Ota M; Katsuura Y; Komoriya K; Nakagaki T
Arzneimittelforschung; 2000 Sep; 50(9):809-15. PubMed ID: 11050697
[TBL] [Abstract][Full Text] [Related]
15. Activated protein C, a natural anticoagulant protein, has antioxidant properties and inhibits lipid peroxidation and advanced glycation end products formation.
Yamaji K; Wang Y; Liu Y; Abeyama K; Hashiguchi T; Uchimura T; Krishna Biswas K; Iwamoto H; Maruyama I
Thromb Res; 2005; 115(4):319-25. PubMed ID: 15668192
[TBL] [Abstract][Full Text] [Related]
16. Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B and activator protein-1 in human monocytes.
Yuksel M; Okajima K; Uchiba M; Horiuchi S; Okabe H
Thromb Haemost; 2002 Aug; 88(2):267-73. PubMed ID: 12195699
[TBL] [Abstract][Full Text] [Related]
17. The role of natural anticoagulants in the pathogenesis and management of systemic activation of coagulation and inflammation in critically ill patients.
Levi M; van der Poll T
Semin Thromb Hemost; 2008 Jul; 34(5):459-68. PubMed ID: 18956286
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulant therapy in critical organ ischaemia/reperfusion injury.
Loubele ST; ten Cate H; Spronk HM
Thromb Haemost; 2010 Jul; 104(1):136-42. PubMed ID: 20431846
[TBL] [Abstract][Full Text] [Related]
19. The protein C pathway.
Esmon CT
Chest; 2003 Sep; 124(3 Suppl):26S-32S. PubMed ID: 12970121
[TBL] [Abstract][Full Text] [Related]
20. Functional difference between membrane-bound and soluble human thrombomodulin.
Miwa Y; Yazaki S; Iwamoto M; Suzuki S; Iwasaki K; Haneda M; Yamamoto K; Maruyama S; Onishi A; Kobayashi T
Transplantation; 2015 Apr; 99(4):702-9. PubMed ID: 25643141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
